Richard Lowenthal, M.S., MSEL
2022
In 2022, Richard Lowenthal, M.S., MSEL earned a total compensation of $476.3K as President and Chief Executive Officer at ARS Pharmaceuticals.
Compensation breakdown
Bonus | $100,000 |
---|---|
Non-Equity Incentive Plan | $188,076 |
Salary | $74,630 |
Other | $113,642 |
Total | $476,348 |
MSEL received $188.1K in non-equity incentive plan, accounting for 39% of the total pay in 2022.
MSEL also received $100K in bonus, $74.6K in salary and $113.6K in other compensation.
Rankings
In 2022, Richard Lowenthal, M.S., MSEL's compensation ranked 4,420th out of 5,760 executives tracked by ExecPay. In other words, MSEL earned more than 23.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,420 out of 5,760 | 23rd |
Division Manufacturing | 2,486 out of 3,136 | 21st |
Major group Chemicals And Allied Products | 1,199 out of 1,422 | 16th |
Industry group Drugs | 1,126 out of 1,323 | 15th |
Industry Pharmaceutical Preparations | 823 out of 969 | 15th |
Source: SEC filing on May 1, 2023.
MSEL's colleagues
We found six more compensation records of executives who worked with Richard Lowenthal, M.S., MSEL at ARS Pharmaceuticals in 2022.
2022
Laura Shawver
ARS Pharmaceuticals
Chief Executive Officer
2022
Valerie Odegard
ARS Pharmaceuticals
Chief Scientific Officer
2022
Jonathan Piazza
ARS Pharmaceuticals
Chief Financial Officer
2022
Jeffrey Pepe
ARS Pharmaceuticals
Chief Executive Officer
2022
Sarina Tanimoto
ARS Pharmaceuticals
Chief Medical Officer
2022
Eric Karas
ARS Pharmaceuticals